Three UCSF Faculty Elected to National Academy of Sciences in 2021
Three faculty members from UCSFhave been elected to the National Academy of Sciences (NAS), one of the highest honors accorded to American scientists.
University of California San Francisco
Give to UCSF
Displaying 1471 - 1500 of 16347
-
-
2021 UCSF Alumni Achievement Awards Honor Accomplished Alumni and Rising Leaders
The Alumni Association of UC San Francisco has named seven winners of the 2021 UCSF Alumni Achievement Awards.
-
Many Older Adults Lack Even Simple, Helpful Equipment
-
UC Encourages COVID-19 Vaccinations for University Communities While Reviewing Policy Requirements
The University of California shared the details of a proposed policy on COVID-19 vaccination as part of its engagement with its community as it joins the California State University in supporting immunizations as part of an expected return of students, faculty, academic appointees and staff to in-person instruction across the state this fall.
-
Partnering with City & Community to Deliver Precision Science, Care and Education
-
New Technique Maps Cell Locations, Hinting at Their Roles
-
First of Its Kind Study Links Wildfire Smoke to Skin Disease
A new study suggests that the dangers posed by wildfire smoke may also extend to the largest organ in the human body, and our first line of defense against outside threat: the skin.
-
UCSF to Conduct 2021 Staff Engagement Survey
As part of ongoing efforts to make UC San Francisco a great place to work, UCSF will conduct its annual engagement survey of all staff from April 27 to May 21.
-
Deaths Rising in Workers Using Methylene Chloride Paint Strippers
The study is the first comprehensive review of fatalities linked to the deadly chemical in the United States and identified more deaths than previously reported.
-
Vaccinated Travelers Should Still Avoid Eating and Drinking on Planes, Experts Say
-
New CRISPR Technology Offers Unrivaled Control of Epigenetic Inheritance
Scientists have figured out how to modify CRISPR’s basic architecture to extend its reach beyond the genome and into what’s known as the epigenome.
-
A Very Handy Breakdown of the Most Common Vaccine Side Effects by Age
-
COVID Vaccine Side Effects: Does My Age Matter, and Should I Windmill My Arm?
-
Want to Be Robust at 40-Plus? Meeting Minimum Exercise Guidelines Won’t Cut It
Young adults must step up their exercise routines to reduce their chances of developing high blood pressure or hypertension – a condition that may lead to heart attack and stroke, as well as dementia in later life.
-
Once on the Brink of Eradication, Syphilis Is Raging Again
-
Peter Chin-Hong Explores Identity and History in 2021 Last Lecture
Knowing the whole story matters. That idea was at the heart of the 2021 UCSF Last Lecture, delivered by Peter Chin-Hong, MD, associate dean and professor in the School of Medicine. The
-
Frontline Health Workers Across US Faced Unique Stressors During COVID-19
The study is among the first to assess mental health effects of the pandemic at a geographically diverse sample of emergency rooms.
-
UCSF Partners with San Francisco to Provide Job Training for Local Residents
UCSF is contributing up to $1.1 million to CityBuild Academy – a construction training program run by the San Francisco Office of Economic and Workforce Development.
-
Researchers Identify Five New Cases of ‘Double Mutant’ COVID Variant in California
-
UCSF Doctor Answers Questions on COVID-19 Vaccine Side Effects, Workplace Requirements, Reopening Plans
-
Accelerated Cellular Aging Associated with Mortality Seen in Depressed Individuals
Cells from individuals with Major Depressive Disorder (MDD) were found to have higher than expected rates of methylation at specific sites on their DNA, when compared to cells from healthy individuals without MDD, according to a study by a multidisciplinary team of UCSF, in collaboration with others.
-
For COVID-19 Long-Haulers, Few Answers, But Meditation and Peer Support Offer Some Relief
While researchers are still striving to understand why some patients experience these “long-haul” symptoms, two UCSF clinicians from complimentary specialties have teamed up to create an integrative medicine skills program that can give such patients better tools to cope with the debilitating symptoms.
-
UCSF Receives 10-Year Accreditation Renewal from WSCUC
UCSF has been granted renewed accreditation from the WASC Senior College and University Commission (WSCUC) for the maximum ten-year accreditation period. WSCUC accreditation ensures that an institution meets rigorous standards of quality and integrity and allows students enrolled in the institution to receive Title IV federal financial aid funding.
-
Making Sense of the CDC’s Seemingly Conflicting Travel Guidelines
-
An Apparent Fourth Wave of COVID-19 Is Centered in the East. Will It Hit California?
-
Experts Grade California’s Vaccine Rollout
-
Experts Discuss Mapping a Post-Pandemic World
In the third installment of UCSF’s three-part series, “COVID-19: The Path Forward,” a panel of health and policy experts met March 23 to examine COVID-19's impact on our society and look ahead to how we rebuild and prepare for future pandemics.
-
Pancreatic Cancer Cells Hijack Muscle Protein to Beef Up Their Metabolism
Cancer starts with mutations in a cell’s DNA, but new UCSF research shows that the endurance of a tumor relies on its ability to rapidly evolve and adapt to challenges brought about by the environment in which it grows.
-
Vaccine Willingness Differs Among Bay Area Medical Workers and General Public
A survey of medical workers and community residents in six Bay Area Counties in the early weeks of vaccine rollout found that Black, Latinx and Asian individuals were more likely than white individuals to report concern that the government had rushed the approval process, and they were less likely to trust the companies making the vaccines.
-
UC Consortium Launches First Clinical Trial Using CRISPR to Correct Gene Defect That Causes Sickle Cell Disease
Scientists at UC San Francisco, UC Berkeley and UCLA have received U.S. Food and Drug Administration approval to jointly launch an early phase, first-in-human clinical trial of a CRISPR gene correction therapy in patients with sickle cell disease using the patient’s own blood-forming stem cells.
